STEVEN BARBERE: Open Payments
NPI 1568487908 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 32 payments from 11 companies in 2025. Trend: 2023 $753 · 2024 $1,151 · 2025 $604
Food & beverage: $604
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $154 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| Exact Sciences Corporation | 3 | $64 |
| Novo Nordisk Inc | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| PFIZER INC. | 3 | $55 |
| Lilly USA, LLC | 2 | $46 |
| ABBVIE INC. | 2 | $36 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Corcept Therapeutics | 1 | $20 |
Products named: The Cologuard Plus Collection Kit, Kerendia, FARXIGA, PREVNAR 20, AIRSUPRA, BREZTRI, JARDIANCE, SHINGRIX.
Industry payments across CA — which companies pay providers there.
